Public confidence in the FDA is low and big changes may be in order to fix the system for approving and regulating drugs, according to a new report by the Institute of Medicine (IOM).
Initiated by the agency itself, the report concludes that Congress, the FDA and the pharmaceutical industry share responsibility for the problems and should bare the burden for developing and implementing solutions.
In response, industry, consumer and patient groups, along with the last three secretaries of the Health and Human Services department, have announced the creation of the Coalition for a Stronger FDA, which will lobby for more FDA funding.
The complete review is available at http://www.iom.edu/CMS/3793/26341/37329.aspx